IL37 and COVID-19: IL-37 exerts significant anti-inflammatory and metaboregulatory effects, dramatically reducing cytokine secretion in macrophages and dendritic cells, with higher early IL-37 responses in COVID-19 patients leading to earlier viral RNA negative conversion (Wang et al., 2018; Yi et al., 2020).